Prostate cancer trials in Finland

In Finland 25 Also abroad 1481

25 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Where
Kuopio, Tampere, Turku
Age
18 years and over
People
1,310 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06136624 · EU 2023-504899-25-00
Phase 3Taking people
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Where
Helsinki, Kuopio, Oulu, Tampere, Turku
Age
18 years and over
People
900 worldwide
Run by
Pfizer
See details and how to joinNCT06629779 · EU 2024-511652-40-00
Phase 1/2Taking people
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
Where
Kuopio
Age
18 years and over
People
160 worldwide
Run by
Eikon Therapeutics
See details and how to joinNCT07262619 · EU 2026-525248-13-00
No phaseTaking people
A Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical Practice
Where
Many Locations
Age
18 years and over
People
1,600 worldwide
Run by
Bayer
See details and how to joinNCT07344779
Phase 3Taking people
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Where
Kuopio
Age
18 years and over
People
670 worldwide
Run by
AstraZeneca
See details and how to joinNCT07611110
Phase 3Taking people
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Where
Helsinki, Kuopio, Oulu, Tampere, Turku
Age
18 years and over
People
700 worldwide
Run by
AstraZeneca
See details and how to joinNCT06952803 · EU 2024-513586-39-00
Phase 3Taking people
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Where
Helsinki, Kuopio, Oulu, Tampere, Turku, Vaasa
Age
18 years and over
People
1,000 worldwide
Run by
Pfizer
See details and how to joinNCT07028853 · EU 2024-519369-24-00
Phase 3Taking people
Impact of atorvastatin on prostate cancer progression after initiation of androgen deprivation therapy
Where
Helsinki, Jyvaskyla, Seinajoki, Tampere, Turku
Age
18 years and over
People
400 worldwide
Run by
Pirkanmaan hyvinvointialue
See details and how to join2024-517854-91-00 · EU 2024-517854-91-00
Phase 2Taking people
Transdermal estradiol and exercise in mitigating adverse effects of androgen deprivation therapy for prostate cancer radiation therapy (ESTRACISE)
Where
Jyvaskyla, Tampere, Turku
Age
18 years and over
People
310
Run by
Varsinais-Suomen hyvinvointialue
See details and how to join2023-504704-28-00 · EU 2023-504704-28-00
Phase 3Taking people
Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer
Where
Helsinki, Tampere, Turku
Age
75 years and over
People
980 worldwide
Run by
Sven Löffeler
See details and how to joinNCT05448547
No phaseTaking people
A COhort Study on Factors Leading to Vulnerability in Adult Patients With Serious Medical cOnditionS: the COSMOS-I Trial
Where
Tampere
People
2,050
Run by
Tampere University Hospital
See details and how to joinNCT07740239
Phase 1Taking people
First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
Where
Helsinki, Kuopio, Tampere, Turku
Age
18 years and over
People
198 worldwide
Run by
Bayer
See details and how to joinNCT06217822 · EU 2023-507486-26-00
Phase 3Taking people
Measuring Oncological Value of Exercise and Statin (MOVES)
Where
Tampere
Age
18 years and over
People
240
Run by
Pirkanmaan hyvinvointialue
See details and how to join2024-515109-24-00 · EU 2024-515109-24-00
No phaseTaking people
Evolution of Lesions in Repeated Biparametric Prostate Magnetic Resonance Imaging
Where
Kuopio
Age
40 years and over
People
100
Run by
University of Eastern Finland
See details and how to joinNCT07369570
Phase 3Taking people
Measuring Oncological Value of Exercise and Statin
Where
Tampere
Age
18 years to 99 years
People
240
Run by
Tampere University Hospital
See details and how to joinNCT05796973
No phaseEnrolling by invitation
A Randomized Trial of Early Detection of Clinically Significant Prostate Cancer (ProScreen)
Where
Helsinki, Tampere
Age
50 years to 63 years
People
17,400
Run by
Tampere University
See details and how to joinNCT03423303
Phase 3Taking people
ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer
Where
Helsinki
Age
18 years and over
People
750 worldwide
Run by
Karolinska Institutet
See details and how to joinNCT03903835 · EU 2023-506857-40-00
No phaseTaking people
Kuopio Lutetium-177 Study in Patients with PSMA-Positive Metastatic Prostate Cancer
Where
Kuopio
Age
18 years and over
People
150
Run by
Kuopio University Hospital
See details and how to joinNCT06850545
Phase 2Taking people
The effect of androgen deprivation therapy on the expression of prostate specific membrane antigen (PSMA) in treatment naive metastatic prostate cancer
Where
Turku
Age
18 years and over
People
35
Run by
Turku University Hospital
See details and how to joinNCT03876912 · EU 2024-519516-14-01
Phase 2Not yet taking people in Finland
Molecular theranostics for metastatic prostate cancer: PSMA, FAPI, or both?
Where
Turku
Age
18 years and over
People
40
Run by
Turku University Hospital
See details and how to join2024-511104-16-00 · EU 2024-511104-16-00
Phase 2/3Taking people
99mTc-MIP-1404 SPECT/CT in Primary Staging of Prostate Cancer
Where
Turku
Age
18 years and over
People
320
Run by
Turku University Hospital
See details and how to joinNCT06219746 · EU 2024-516083-28-00
Phase 4Taking people
Prostate Medication, Metabolism and Gut Microbiota
Where
Turku
Age
18 years and over
People
100
Run by
Turku University Hospital
See details and how to joinNCT06001619
Phase 4Taking people
Prostate medication, metabolism and gut microbiota, PROMED.
Where
Turku
Age
18 years and over
People
100
Run by
Turku University Central Hospital
See details and how to join2022-500618-24-00 · EU 2022-500618-24-00
No phaseTaking people
Surgery Versus Radiotherapy for Locally Advanced Prostate Cancer
Where
Helsinki, Tampere, Turku
Age
18 years to 75 years
People
1,200 worldwide
Run by
Olof Akre
See details and how to joinNCT02102477
No phaseTaking people
bpMRI and Risk Based Shared Clinical Decision Making in Prostate Cancer Diagnosis
Where
Jyväskylä, Pori, Tampere, Turku
Age
18 years and over
People
600
Run by
Turku University Hospital
See details and how to joinNCT04287088